nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC11—Methotrexate—psoriasis	0.0746	0.0877	CbGbCtD
Probenecid—SLC10A1—Cyclosporine—psoriasis	0.07	0.0823	CbGbCtD
Probenecid—ABCC3—Cyclosporine—psoriasis	0.0389	0.0457	CbGbCtD
Probenecid—SLC16A1—Methotrexate—psoriasis	0.0327	0.0385	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—psoriasis	0.0327	0.0385	CbGbCtD
Probenecid—ALB—Acitretin—psoriasis	0.0311	0.0365	CbGbCtD
Probenecid—CYP2C8—Tazarotene—psoriasis	0.0304	0.0357	CbGbCtD
Probenecid—ABCC1—Cyclosporine—psoriasis	0.0239	0.0281	CbGbCtD
Probenecid—SLCO1A2—Prednisolone—psoriasis	0.0238	0.028	CbGbCtD
Probenecid—ABCC2—Mycophenolate mofetil—psoriasis	0.0233	0.0274	CbGbCtD
Probenecid—SLCO1A2—Hydrocortisone—psoriasis	0.0226	0.0266	CbGbCtD
Probenecid—SLCO1A2—Prednisone—psoriasis	0.0225	0.0265	CbGbCtD
Probenecid—SLCO1A2—Cyclosporine—psoriasis	0.0213	0.0251	CbGbCtD
Probenecid—ABCC3—Methotrexate—psoriasis	0.0206	0.0242	CbGbCtD
Probenecid—ABCC2—Cyclosporine—psoriasis	0.0177	0.0208	CbGbCtD
Probenecid—SLC22A11—Methotrexate—psoriasis	0.0169	0.0199	CbGbCtD
Probenecid—SLC22A7—Methotrexate—psoriasis	0.0161	0.0189	CbGbCtD
Probenecid—ABCC4—Methotrexate—psoriasis	0.0157	0.0185	CbGbCtD
Probenecid—SLC2A9—skeletal joint—psoriasis	0.0146	0.468	CbGeAlD
Probenecid—ALB—Mycophenolate mofetil—psoriasis	0.0145	0.0171	CbGbCtD
Probenecid—SLCO1A2—Dexamethasone—psoriasis	0.014	0.0165	CbGbCtD
Probenecid—CYP2C8—Cholecalciferol—psoriasis	0.013	0.0152	CbGbCtD
Probenecid—SLC22A6—Cyclosporine—psoriasis	0.0129	0.0152	CbGbCtD
Probenecid—ABCC1—Methotrexate—psoriasis	0.0126	0.0149	CbGbCtD
Probenecid—ABCC2—Dexamethasone—psoriasis	0.0116	0.0137	CbGbCtD
Probenecid—ALB—Prednisone—psoriasis	0.0116	0.0137	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—psoriasis	0.0113	0.0133	CbGbCtD
Probenecid—CYP2C8—Mycophenolate mofetil—psoriasis	0.0112	0.0132	CbGbCtD
Probenecid—CYP2C19—Cholecalciferol—psoriasis	0.0109	0.0128	CbGbCtD
Probenecid—ABCC6—dermis—psoriasis	0.0102	0.329	CbGeAlD
Probenecid—CYP3A4—Calcitriol—psoriasis	0.0102	0.012	CbGbCtD
Probenecid—SLC22A8—Methotrexate—psoriasis	0.00983	0.0116	CbGbCtD
Probenecid—ABCC2—Methotrexate—psoriasis	0.00936	0.011	CbGbCtD
Probenecid—CYP2C9—Cholecalciferol—psoriasis	0.00904	0.0106	CbGbCtD
Probenecid—CYP2C8—Hydrocortisone—psoriasis	0.00902	0.0106	CbGbCtD
Probenecid—CYP2C8—Cyclosporine—psoriasis	0.00851	0.01	CbGbCtD
Probenecid—CYP3A4—Methoxsalen—psoriasis	0.00793	0.00933	CbGbCtD
Probenecid—ABCB1—Mycophenolate mofetil—psoriasis	0.00761	0.00894	CbGbCtD
Probenecid—CYP2C19—Prednisone—psoriasis	0.00754	0.00886	CbGbCtD
Probenecid—CYP2C19—Cyclosporine—psoriasis	0.00714	0.0084	CbGbCtD
Probenecid—SLC22A6—Methotrexate—psoriasis	0.00685	0.00805	CbGbCtD
Probenecid—ABCB1—Betamethasone—psoriasis	0.00652	0.00767	CbGbCtD
Probenecid—ABCB1—Prednisolone—psoriasis	0.00644	0.00757	CbGbCtD
Probenecid—ABCB1—Hydrocortisone—psoriasis	0.0061	0.00718	CbGbCtD
Probenecid—ABCB1—Prednisone—psoriasis	0.00608	0.00715	CbGbCtD
Probenecid—CYP2C9—Cyclosporine—psoriasis	0.00594	0.00698	CbGbCtD
Probenecid—ALB—Methotrexate—psoriasis	0.00583	0.00686	CbGbCtD
Probenecid—ABCB1—Cyclosporine—psoriasis	0.00576	0.00678	CbGbCtD
Probenecid—CYP2C8—Dexamethasone—psoriasis	0.00561	0.00659	CbGbCtD
Probenecid—CYP3A4—Cholecalciferol—psoriasis	0.00526	0.00618	CbGbCtD
Probenecid—CYP2C19—Dexamethasone—psoriasis	0.0047	0.00553	CbGbCtD
Probenecid—CYP3A4—Mycophenolate mofetil—psoriasis	0.00456	0.00536	CbGbCtD
Probenecid—CYP3A4—Triamcinolone—psoriasis	0.00456	0.00536	CbGbCtD
Probenecid—CYP2C9—Dexamethasone—psoriasis	0.00391	0.0046	CbGbCtD
Probenecid—CYP3A4—Betamethasone—psoriasis	0.00391	0.0046	CbGbCtD
Probenecid—CYP3A4—Prednisolone—psoriasis	0.00386	0.00454	CbGbCtD
Probenecid—ABCB1—Dexamethasone—psoriasis	0.0038	0.00446	CbGbCtD
Probenecid—CYP3A4—Hydrocortisone—psoriasis	0.00366	0.0043	CbGbCtD
Probenecid—CYP3A4—Prednisone—psoriasis	0.00364	0.00428	CbGbCtD
Probenecid—CYP3A4—Cyclosporine—psoriasis	0.00345	0.00406	CbGbCtD
Probenecid—ABCB1—Methotrexate—psoriasis	0.00305	0.00359	CbGbCtD
Probenecid—CYP3A4—Dexamethasone—psoriasis	0.00227	0.00267	CbGbCtD
Probenecid—PANX1—tendon—psoriasis	0.00185	0.0593	CbGeAlD
Probenecid—Pain—Calcipotriol—psoriasis	0.00131	0.0168	CcSEcCtD
Probenecid—Alopecia—Clobetasol propionate—psoriasis	0.00119	0.0153	CcSEcCtD
Probenecid—Hypersensitivity—Calcipotriol—psoriasis	0.00113	0.0145	CcSEcCtD
Probenecid—Pruritus—Calcipotriol—psoriasis	0.00108	0.0139	CcSEcCtD
Probenecid—SLC16A7—tendon—psoriasis	0.000987	0.0317	CbGeAlD
Probenecid—Pain—Tazarotene—psoriasis	0.000965	0.0124	CcSEcCtD
Probenecid—Dermatitis—Calcipotriol—psoriasis	0.000964	0.0124	CcSEcCtD
Probenecid—Anaphylactic shock—Beclomethasone—psoriasis	0.000871	0.0112	CcSEcCtD
Probenecid—Pain—Clobetasol propionate—psoriasis	0.000818	0.0105	CcSEcCtD
Probenecid—Erythema multiforme—Calcitriol—psoriasis	0.000808	0.0104	CcSEcCtD
Probenecid—Haematuria—Acitretin—psoriasis	0.000808	0.0104	CcSEcCtD
Probenecid—Pruritus—Tazarotene—psoriasis	0.000799	0.0103	CcSEcCtD
Probenecid—Pain—Beclomethasone—psoriasis	0.000745	0.00956	CcSEcCtD
Probenecid—Pain—Fluocinonide—psoriasis	0.000738	0.00947	CcSEcCtD
Probenecid—Aplastic anaemia—Mycophenolate mofetil—psoriasis	0.000738	0.00947	CcSEcCtD
Probenecid—Dermatitis—Tazarotene—psoriasis	0.000711	0.00913	CcSEcCtD
Probenecid—Flushing—Acitretin—psoriasis	0.000706	0.00906	CcSEcCtD
Probenecid—Hypersensitivity—Clobetasol propionate—psoriasis	0.000705	0.00905	CcSEcCtD
Probenecid—Urticaria—Beclomethasone—psoriasis	0.000692	0.00888	CcSEcCtD
Probenecid—ABCC5—tendon—psoriasis	0.000691	0.0222	CbGeAlD
Probenecid—Pruritus—Clobetasol propionate—psoriasis	0.000677	0.00869	CcSEcCtD
Probenecid—Alopecia—Acitretin—psoriasis	0.000672	0.00862	CcSEcCtD
Probenecid—Alopecia—Fluocinolone Acetonide—psoriasis	0.00067	0.0086	CcSEcCtD
Probenecid—Hypersensitivity—Fluocinonide—psoriasis	0.000636	0.00816	CcSEcCtD
Probenecid—Haemolytic anaemia—Mycophenolate mofetil—psoriasis	0.000632	0.00811	CcSEcCtD
Probenecid—SLC16A1—tendon—psoriasis	0.000628	0.0202	CbGeAlD
Probenecid—Pruritus—Fluocinonide—psoriasis	0.000611	0.00784	CcSEcCtD
Probenecid—Anaphylactic shock—Calcitriol—psoriasis	0.000607	0.00779	CcSEcCtD
Probenecid—Dermatitis—Clobetasol propionate—psoriasis	0.000603	0.00774	CcSEcCtD
Probenecid—Headache—Clobetasol propionate—psoriasis	0.000599	0.00769	CcSEcCtD
Probenecid—Anorexia—Calcitriol—psoriasis	0.000579	0.00743	CcSEcCtD
Probenecid—Pollakiuria—Mycophenolic acid—psoriasis	0.000577	0.00741	CcSEcCtD
Probenecid—Dizziness—Beclomethasone—psoriasis	0.000576	0.00739	CcSEcCtD
Probenecid—Dizziness—Fluocinonide—psoriasis	0.000571	0.00733	CcSEcCtD
Probenecid—Dermatitis—Beclomethasone—psoriasis	0.000549	0.00704	CcSEcCtD
Probenecid—Headache—Beclomethasone—psoriasis	0.000546	0.007	CcSEcCtD
Probenecid—Dermatitis—Fluocinonide—psoriasis	0.000544	0.00698	CcSEcCtD
Probenecid—Urticaria—Methoxsalen—psoriasis	0.000541	0.00695	CcSEcCtD
Probenecid—Headache—Fluocinonide—psoriasis	0.000541	0.00694	CcSEcCtD
Probenecid—Body temperature increased—Methoxsalen—psoriasis	0.000539	0.00691	CcSEcCtD
Probenecid—Haematuria—Mycophenolic acid—psoriasis	0.000531	0.00682	CcSEcCtD
Probenecid—Decreased appetite—Calcitriol—psoriasis	0.000528	0.00678	CcSEcCtD
Probenecid—Alopecia—Hydroxyurea—psoriasis	0.000528	0.00677	CcSEcCtD
Probenecid—Pain—Calcitriol—psoriasis	0.000519	0.00666	CcSEcCtD
Probenecid—Nausea—Beclomethasone—psoriasis	0.000517	0.00664	CcSEcCtD
Probenecid—Anorexia—Acitretin—psoriasis	0.000515	0.00661	CcSEcCtD
Probenecid—Hypersensitivity—Methoxsalen—psoriasis	0.000502	0.00644	CcSEcCtD
Probenecid—Urticaria—Calcitriol—psoriasis	0.000482	0.00619	CcSEcCtD
Probenecid—Pruritus—Methoxsalen—psoriasis	0.000482	0.00619	CcSEcCtD
Probenecid—Anaemia—Hydroxyurea—psoriasis	0.00048	0.00616	CcSEcCtD
Probenecid—Body temperature increased—Calcitriol—psoriasis	0.00048	0.00616	CcSEcCtD
Probenecid—ABCC4—tendon—psoriasis	0.000479	0.0154	CbGeAlD
Probenecid—SLC22A5—skin of body—psoriasis	0.000472	0.0151	CbGeAlD
Probenecid—Decreased appetite—Acitretin—psoriasis	0.00047	0.00603	CcSEcCtD
Probenecid—Pollakiuria—Cyclosporine—psoriasis	0.000467	0.00599	CcSEcCtD
Probenecid—Leukopenia—Hydroxyurea—psoriasis	0.000465	0.00597	CcSEcCtD
Probenecid—ABCC2—tendon—psoriasis	0.000463	0.0149	CbGeAlD
Probenecid—Pain—Acitretin—psoriasis	0.000462	0.00593	CcSEcCtD
Probenecid—Pain—Fluocinolone Acetonide—psoriasis	0.000461	0.00591	CcSEcCtD
Probenecid—Pollakiuria—Mycophenolate mofetil—psoriasis	0.000455	0.00585	CcSEcCtD
Probenecid—Dizziness—Methoxsalen—psoriasis	0.000451	0.00578	CcSEcCtD
Probenecid—Hypersensitivity—Calcitriol—psoriasis	0.000447	0.00574	CcSEcCtD
Probenecid—Alopecia—Mycophenolic acid—psoriasis	0.000442	0.00567	CcSEcCtD
Probenecid—Pruritus—Calcitriol—psoriasis	0.00043	0.00551	CcSEcCtD
Probenecid—Haematuria—Cyclosporine—psoriasis	0.00043	0.00551	CcSEcCtD
Probenecid—Dermatitis—Methoxsalen—psoriasis	0.000429	0.00551	CcSEcCtD
Probenecid—Urticaria—Acitretin—psoriasis	0.000429	0.00551	CcSEcCtD
Probenecid—Body temperature increased—Acitretin—psoriasis	0.000427	0.00548	CcSEcCtD
Probenecid—Headache—Methoxsalen—psoriasis	0.000427	0.00548	CcSEcCtD
Probenecid—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000426	0.00547	CcSEcCtD
Probenecid—Haematuria—Mycophenolate mofetil—psoriasis	0.000419	0.00538	CcSEcCtD
Probenecid—Aplastic anaemia—Methotrexate—psoriasis	0.000418	0.00536	CcSEcCtD
Probenecid—ABCC1—tendon—psoriasis	0.000408	0.0131	CbGeAlD
Probenecid—Nausea—Methoxsalen—psoriasis	0.000405	0.00519	CcSEcCtD
Probenecid—Anorexia—Hydroxyurea—psoriasis	0.000404	0.00519	CcSEcCtD
Probenecid—Anaemia—Mycophenolic acid—psoriasis	0.000402	0.00516	CcSEcCtD
Probenecid—Hypersensitivity—Acitretin—psoriasis	0.000398	0.00511	CcSEcCtD
Probenecid—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000397	0.00509	CcSEcCtD
Probenecid—Leukopenia—Mycophenolic acid—psoriasis	0.00039	0.005	CcSEcCtD
Probenecid—Vomiting—Calcitriol—psoriasis	0.000386	0.00496	CcSEcCtD
Probenecid—Dermatitis—Calcitriol—psoriasis	0.000383	0.00491	CcSEcCtD
Probenecid—Pruritus—Acitretin—psoriasis	0.000382	0.00491	CcSEcCtD
Probenecid—Pruritus—Fluocinolone Acetonide—psoriasis	0.000381	0.00489	CcSEcCtD
Probenecid—Headache—Calcitriol—psoriasis	0.00038	0.00488	CcSEcCtD
Probenecid—Flushing—Cyclosporine—psoriasis	0.000375	0.00482	CcSEcCtD
Probenecid—Decreased appetite—Hydroxyurea—psoriasis	0.000369	0.00473	CcSEcCtD
Probenecid—Pain—Hydroxyurea—psoriasis	0.000363	0.00466	CcSEcCtD
Probenecid—Nausea—Calcitriol—psoriasis	0.000361	0.00463	CcSEcCtD
Probenecid—SLC22A5—tendon—psoriasis	0.000359	0.0115	CbGeAlD
Probenecid—Alopecia—Cyclosporine—psoriasis	0.000357	0.00459	CcSEcCtD
Probenecid—Dizziness—Acitretin—psoriasis	0.000357	0.00459	CcSEcCtD
Probenecid—Dizziness—Fluocinolone Acetonide—psoriasis	0.000356	0.00457	CcSEcCtD
Probenecid—Alopecia—Mycophenolate mofetil—psoriasis	0.000349	0.00448	CcSEcCtD
Probenecid—Vomiting—Acitretin—psoriasis	0.000343	0.00441	CcSEcCtD
Probenecid—Vomiting—Fluocinolone Acetonide—psoriasis	0.000343	0.0044	CcSEcCtD
Probenecid—Dermatitis—Acitretin—psoriasis	0.00034	0.00437	CcSEcCtD
Probenecid—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000339	0.00436	CcSEcCtD
Probenecid—Anorexia—Mycophenolic acid—psoriasis	0.000339	0.00435	CcSEcCtD
Probenecid—Headache—Acitretin—psoriasis	0.000338	0.00434	CcSEcCtD
Probenecid—Headache—Fluocinolone Acetonide—psoriasis	0.000337	0.00433	CcSEcCtD
Probenecid—Body temperature increased—Hydroxyurea—psoriasis	0.000335	0.0043	CcSEcCtD
Probenecid—Anaemia—Cyclosporine—psoriasis	0.000325	0.00418	CcSEcCtD
Probenecid—Nausea—Acitretin—psoriasis	0.000321	0.00412	CcSEcCtD
Probenecid—Nausea—Fluocinolone Acetonide—psoriasis	0.00032	0.00411	CcSEcCtD
Probenecid—Anaemia—Mycophenolate mofetil—psoriasis	0.000317	0.00407	CcSEcCtD
Probenecid—Leukopenia—Cyclosporine—psoriasis	0.000315	0.00405	CcSEcCtD
Probenecid—Hypersensitivity—Hydroxyurea—psoriasis	0.000312	0.00401	CcSEcCtD
Probenecid—Decreased appetite—Mycophenolic acid—psoriasis	0.000309	0.00396	CcSEcCtD
Probenecid—Leukopenia—Mycophenolate mofetil—psoriasis	0.000307	0.00395	CcSEcCtD
Probenecid—Pain—Mycophenolic acid—psoriasis	0.000304	0.0039	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000291	0.00373	CcSEcCtD
Probenecid—Anaphylactic shock—Cyclosporine—psoriasis	0.000287	0.00369	CcSEcCtD
Probenecid—Body temperature increased—Mycophenolic acid—psoriasis	0.000281	0.0036	CcSEcCtD
Probenecid—Dizziness—Hydroxyurea—psoriasis	0.00028	0.0036	CcSEcCtD
Probenecid—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00028	0.0036	CcSEcCtD
Probenecid—Anorexia—Cyclosporine—psoriasis	0.000274	0.00352	CcSEcCtD
Probenecid—Alopecia—Dexamethasone—psoriasis	0.000271	0.00348	CcSEcCtD
Probenecid—Alopecia—Betamethasone—psoriasis	0.000271	0.00348	CcSEcCtD
Probenecid—Vomiting—Hydroxyurea—psoriasis	0.00027	0.00346	CcSEcCtD
Probenecid—Anorexia—Mycophenolate mofetil—psoriasis	0.000267	0.00343	CcSEcCtD
Probenecid—Dermatitis—Hydroxyurea—psoriasis	0.000267	0.00343	CcSEcCtD
Probenecid—Headache—Hydroxyurea—psoriasis	0.000266	0.00341	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisolone—psoriasis	0.000261	0.00336	CcSEcCtD
Probenecid—Anaphylactic shock—Hydrocortisone—psoriasis	0.000255	0.00328	CcSEcCtD
Probenecid—Nausea—Hydroxyurea—psoriasis	0.000252	0.00323	CcSEcCtD
Probenecid—Pruritus—Mycophenolic acid—psoriasis	0.000251	0.00323	CcSEcCtD
Probenecid—Decreased appetite—Cyclosporine—psoriasis	0.00025	0.00321	CcSEcCtD
Probenecid—Flushing—Prednisone—psoriasis	0.000248	0.00319	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000247	0.00317	CcSEcCtD
Probenecid—Pain—Cyclosporine—psoriasis	0.000246	0.00315	CcSEcCtD
Probenecid—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000244	0.00313	CcSEcCtD
Probenecid—Anorexia—Hydrocortisone—psoriasis	0.000243	0.00312	CcSEcCtD
Probenecid—Anaphylactic shock—Triamcinolone—psoriasis	0.00024	0.00309	CcSEcCtD
Probenecid—Pain—Mycophenolate mofetil—psoriasis	0.00024	0.00308	CcSEcCtD
Probenecid—Haematuria—Methotrexate—psoriasis	0.000237	0.00305	CcSEcCtD
Probenecid—Alopecia—Prednisone—psoriasis	0.000236	0.00303	CcSEcCtD
Probenecid—Dizziness—Mycophenolic acid—psoriasis	0.000235	0.00301	CcSEcCtD
Probenecid—Urticaria—Cyclosporine—psoriasis	0.000228	0.00293	CcSEcCtD
Probenecid—Body temperature increased—Cyclosporine—psoriasis	0.000227	0.00292	CcSEcCtD
Probenecid—Vomiting—Mycophenolic acid—psoriasis	0.000226	0.0029	CcSEcCtD
Probenecid—Dermatitis—Mycophenolic acid—psoriasis	0.000224	0.00287	CcSEcCtD
Probenecid—Pain—Prednisolone—psoriasis	0.000224	0.00287	CcSEcCtD
Probenecid—Urticaria—Mycophenolate mofetil—psoriasis	0.000223	0.00286	CcSEcCtD
Probenecid—Headache—Mycophenolic acid—psoriasis	0.000223	0.00286	CcSEcCtD
Probenecid—Decreased appetite—Hydrocortisone—psoriasis	0.000222	0.00285	CcSEcCtD
Probenecid—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000222	0.00284	CcSEcCtD
Probenecid—Pain—Hydrocortisone—psoriasis	0.000218	0.0028	CcSEcCtD
Probenecid—Anaphylactic shock—Dexamethasone—psoriasis	0.000218	0.0028	CcSEcCtD
Probenecid—Anaphylactic shock—Betamethasone—psoriasis	0.000218	0.0028	CcSEcCtD
Probenecid—Anaemia—Prednisone—psoriasis	0.000215	0.00276	CcSEcCtD
Probenecid—Hypersensitivity—Cyclosporine—psoriasis	0.000212	0.00272	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—psoriasis	0.000211	0.00271	CcSEcCtD
Probenecid—Nausea—Mycophenolic acid—psoriasis	0.000211	0.00271	CcSEcCtD
Probenecid—Anorexia—Dexamethasone—psoriasis	0.000208	0.00267	CcSEcCtD
Probenecid—Anorexia—Betamethasone—psoriasis	0.000208	0.00267	CcSEcCtD
Probenecid—Urticaria—Prednisolone—psoriasis	0.000208	0.00267	CcSEcCtD
Probenecid—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000207	0.00265	CcSEcCtD
Probenecid—Pain—Triamcinolone—psoriasis	0.000206	0.00264	CcSEcCtD
Probenecid—Pruritus—Cyclosporine—psoriasis	0.000203	0.00261	CcSEcCtD
Probenecid—Urticaria—Hydrocortisone—psoriasis	0.000203	0.0026	CcSEcCtD
Probenecid—Body temperature increased—Hydrocortisone—psoriasis	0.000202	0.00259	CcSEcCtD
Probenecid—Pruritus—Mycophenolate mofetil—psoriasis	0.000198	0.00255	CcSEcCtD
Probenecid—Alopecia—Methotrexate—psoriasis	0.000198	0.00254	CcSEcCtD
Probenecid—Hypersensitivity—Prednisolone—psoriasis	0.000193	0.00247	CcSEcCtD
Probenecid—Urticaria—Triamcinolone—psoriasis	0.000191	0.00245	CcSEcCtD
Probenecid—Body temperature increased—Triamcinolone—psoriasis	0.00019	0.00244	CcSEcCtD
Probenecid—Dizziness—Cyclosporine—psoriasis	0.00019	0.00244	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—psoriasis	0.00019	0.00244	CcSEcCtD
Probenecid—Decreased appetite—Betamethasone—psoriasis	0.00019	0.00243	CcSEcCtD
Probenecid—Decreased appetite—Dexamethasone—psoriasis	0.00019	0.00243	CcSEcCtD
Probenecid—Hypersensitivity—Hydrocortisone—psoriasis	0.000188	0.00242	CcSEcCtD
Probenecid—Pain—Dexamethasone—psoriasis	0.000187	0.00239	CcSEcCtD
Probenecid—Pain—Betamethasone—psoriasis	0.000187	0.00239	CcSEcCtD
Probenecid—Dizziness—Mycophenolate mofetil—psoriasis	0.000185	0.00238	CcSEcCtD
Probenecid—Vomiting—Cyclosporine—psoriasis	0.000183	0.00235	CcSEcCtD
Probenecid—Anorexia—Prednisone—psoriasis	0.000181	0.00232	CcSEcCtD
Probenecid—Dermatitis—Cyclosporine—psoriasis	0.000181	0.00232	CcSEcCtD
Probenecid—Pruritus—Hydrocortisone—psoriasis	0.000181	0.00232	CcSEcCtD
Probenecid—Headache—Cyclosporine—psoriasis	0.00018	0.00231	CcSEcCtD
Probenecid—Anaemia—Methotrexate—psoriasis	0.00018	0.00231	CcSEcCtD
Probenecid—Vomiting—Mycophenolate mofetil—psoriasis	0.000178	0.00229	CcSEcCtD
Probenecid—Hypersensitivity—Triamcinolone—psoriasis	0.000177	0.00227	CcSEcCtD
Probenecid—Dermatitis—Mycophenolate mofetil—psoriasis	0.000177	0.00227	CcSEcCtD
Probenecid—Headache—Mycophenolate mofetil—psoriasis	0.000176	0.00225	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—psoriasis	0.000174	0.00224	CcSEcCtD
Probenecid—Urticaria—Betamethasone—psoriasis	0.000173	0.00222	CcSEcCtD
Probenecid—Urticaria—Dexamethasone—psoriasis	0.000173	0.00222	CcSEcCtD
Probenecid—Dizziness—Prednisolone—psoriasis	0.000173	0.00222	CcSEcCtD
Probenecid—Body temperature increased—Dexamethasone—psoriasis	0.000172	0.00221	CcSEcCtD
Probenecid—Body temperature increased—Betamethasone—psoriasis	0.000172	0.00221	CcSEcCtD
Probenecid—Nausea—Cyclosporine—psoriasis	0.000171	0.00219	CcSEcCtD
Probenecid—Pruritus—Triamcinolone—psoriasis	0.00017	0.00218	CcSEcCtD
Probenecid—Dizziness—Hydrocortisone—psoriasis	0.000169	0.00217	CcSEcCtD
Probenecid—Nausea—Mycophenolate mofetil—psoriasis	0.000167	0.00214	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—psoriasis	0.000165	0.00212	CcSEcCtD
Probenecid—Dermatitis—Prednisolone—psoriasis	0.000165	0.00211	CcSEcCtD
Probenecid—Headache—Prednisolone—psoriasis	0.000164	0.0021	CcSEcCtD
Probenecid—Vomiting—Hydrocortisone—psoriasis	0.000162	0.00208	CcSEcCtD
Probenecid—Dermatitis—Hydrocortisone—psoriasis	0.000161	0.00206	CcSEcCtD
Probenecid—Headache—Hydrocortisone—psoriasis	0.00016	0.00205	CcSEcCtD
Probenecid—Dizziness—Triamcinolone—psoriasis	0.000159	0.00204	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—psoriasis	0.000159	0.00204	CcSEcCtD
Probenecid—Nausea—Prednisolone—psoriasis	0.000155	0.00199	CcSEcCtD
Probenecid—Pruritus—Dexamethasone—psoriasis	0.000154	0.00198	CcSEcCtD
Probenecid—Pruritus—Betamethasone—psoriasis	0.000154	0.00198	CcSEcCtD
Probenecid—Vomiting—Triamcinolone—psoriasis	0.000153	0.00196	CcSEcCtD
Probenecid—Nausea—Hydrocortisone—psoriasis	0.000152	0.00195	CcSEcCtD
Probenecid—Dermatitis—Triamcinolone—psoriasis	0.000151	0.00194	CcSEcCtD
Probenecid—Anorexia—Methotrexate—psoriasis	0.000151	0.00194	CcSEcCtD
Probenecid—Urticaria—Prednisone—psoriasis	0.000151	0.00194	CcSEcCtD
Probenecid—Headache—Triamcinolone—psoriasis	0.000151	0.00193	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—psoriasis	0.00015	0.00193	CcSEcCtD
Probenecid—Dizziness—Betamethasone—psoriasis	0.000144	0.00185	CcSEcCtD
Probenecid—Dizziness—Dexamethasone—psoriasis	0.000144	0.00185	CcSEcCtD
Probenecid—Nausea—Triamcinolone—psoriasis	0.000143	0.00183	CcSEcCtD
Probenecid—Hypersensitivity—Prednisone—psoriasis	0.00014	0.0018	CcSEcCtD
Probenecid—Vomiting—Betamethasone—psoriasis	0.000139	0.00178	CcSEcCtD
Probenecid—Vomiting—Dexamethasone—psoriasis	0.000139	0.00178	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—psoriasis	0.000138	0.00177	CcSEcCtD
Probenecid—Dermatitis—Betamethasone—psoriasis	0.000137	0.00176	CcSEcCtD
Probenecid—Dermatitis—Dexamethasone—psoriasis	0.000137	0.00176	CcSEcCtD
Probenecid—Headache—Dexamethasone—psoriasis	0.000137	0.00175	CcSEcCtD
Probenecid—Headache—Betamethasone—psoriasis	0.000137	0.00175	CcSEcCtD
Probenecid—Pain—Methotrexate—psoriasis	0.000136	0.00174	CcSEcCtD
Probenecid—Pruritus—Prednisone—psoriasis	0.000134	0.00173	CcSEcCtD
Probenecid—Nausea—Betamethasone—psoriasis	0.00013	0.00166	CcSEcCtD
Probenecid—Nausea—Dexamethasone—psoriasis	0.00013	0.00166	CcSEcCtD
Probenecid—Urticaria—Methotrexate—psoriasis	0.000126	0.00162	CcSEcCtD
Probenecid—Dizziness—Prednisone—psoriasis	0.000126	0.00161	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—psoriasis	0.000126	0.00161	CcSEcCtD
Probenecid—Vomiting—Prednisone—psoriasis	0.000121	0.00155	CcSEcCtD
Probenecid—Dermatitis—Prednisone—psoriasis	0.00012	0.00154	CcSEcCtD
Probenecid—Headache—Prednisone—psoriasis	0.000119	0.00153	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—psoriasis	0.000117	0.0015	CcSEcCtD
Probenecid—Nausea—Prednisone—psoriasis	0.000113	0.00145	CcSEcCtD
Probenecid—Pruritus—Methotrexate—psoriasis	0.000112	0.00144	CcSEcCtD
Probenecid—Dizziness—Methotrexate—psoriasis	0.000105	0.00135	CcSEcCtD
Probenecid—Vomiting—Methotrexate—psoriasis	0.000101	0.0013	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—psoriasis	0.0001	0.00128	CcSEcCtD
Probenecid—Headache—Methotrexate—psoriasis	9.95e-05	0.00128	CcSEcCtD
Probenecid—Nausea—Methotrexate—psoriasis	9.43e-05	0.00121	CcSEcCtD
Probenecid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.09e-05	0.00224	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—TYK2—psoriasis	8.84e-05	0.00218	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CYP2S1—psoriasis	8.8e-05	0.00217	CbGpPWpGaD
Probenecid—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	8.75e-05	0.00216	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL17A—psoriasis	8.43e-05	0.00208	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—ITGAL—psoriasis	8.2e-05	0.00202	CbGpPWpGaD
Probenecid—PANX1—Immune System—CD8A—psoriasis	8.11e-05	0.002	CbGpPWpGaD
Probenecid—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.06e-05	0.00199	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—CD4—psoriasis	8e-05	0.00197	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—CAT—psoriasis	8e-05	0.00197	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—NDUFA5—psoriasis	7.93e-05	0.00196	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL12B—psoriasis	7.84e-05	0.00193	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—CRP—psoriasis	7.8e-05	0.00193	CbGpPWpGaD
Probenecid—PANX1—Immune System—HLA-B—psoriasis	7.8e-05	0.00192	CbGpPWpGaD
Probenecid—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	7.76e-05	0.00191	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—HLA-E—psoriasis	7.65e-05	0.00189	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.64e-05	0.00188	CbGpPWpGaD
Probenecid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.53e-05	0.00186	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—NDUFA5—psoriasis	7.37e-05	0.00182	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	7.37e-05	0.00182	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IL4—psoriasis	7.35e-05	0.00181	CbGpPWpGaD
Probenecid—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	7.3e-05	0.0018	CbGpPWpGaD
Probenecid—PANX1—Immune System—HLA-A—psoriasis	7.23e-05	0.00178	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.17e-05	0.00177	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—JUN—psoriasis	7.16e-05	0.00177	CbGpPWpGaD
Probenecid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.12e-05	0.00176	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	7.03e-05	0.00174	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	6.99e-05	0.00172	CbGpPWpGaD
Probenecid—PANX1—Immune System—CRP—psoriasis	6.9e-05	0.0017	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—NFKB1—psoriasis	6.89e-05	0.0017	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—CP—psoriasis	6.85e-05	0.00169	CbGpPWpGaD
Probenecid—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	6.8e-05	0.00168	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CYP2S1—psoriasis	6.74e-05	0.00166	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.68e-05	0.00165	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	6.67e-05	0.00164	CbGpPWpGaD
Probenecid—PANX1—Immune System—HLA-DRB1—psoriasis	6.6e-05	0.00163	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.59e-05	0.00163	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—CARM1—psoriasis	6.54e-05	0.00161	CbGpPWpGaD
Probenecid—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.4e-05	0.00158	CbGpPWpGaD
Probenecid—ABCC4—Platelet degranulation—VEGFA—psoriasis	6.35e-05	0.00157	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.35e-05	0.00157	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—CRP—psoriasis	6.35e-05	0.00157	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	6.34e-05	0.00156	CbGpPWpGaD
Probenecid—PANX1—Immune System—ICAM1—psoriasis	6.34e-05	0.00156	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.33e-05	0.00156	CbGpPWpGaD
Probenecid—PANX1—Immune System—NFKBIA—psoriasis	6.29e-05	0.00155	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CYP2S1—psoriasis	6.27e-05	0.00155	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—ITGAL—psoriasis	6.11e-05	0.00151	CbGpPWpGaD
Probenecid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	6.05e-05	0.00149	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	6.05e-05	0.00149	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—CP—psoriasis	5.89e-05	0.00145	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—NDUFA5—psoriasis	5.85e-05	0.00144	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—ICAM1—psoriasis	5.84e-05	0.00144	CbGpPWpGaD
Probenecid—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.76e-05	0.00142	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL10—psoriasis	5.73e-05	0.00141	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—CARM1—psoriasis	5.62e-05	0.00139	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL4—psoriasis	5.57e-05	0.00138	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.46e-05	0.00135	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.45e-05	0.00135	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.45e-05	0.00134	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.44e-05	0.00134	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	5.43e-05	0.00134	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	5.33e-05	0.00132	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	5.18e-05	0.00128	CbGpPWpGaD
Probenecid—PANX1—Immune System—TYK2—psoriasis	5.15e-05	0.00127	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	5.11e-05	0.00126	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—NDUFA5—psoriasis	5.09e-05	0.00126	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	5.08e-05	0.00125	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.07e-05	0.00125	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.05e-05	0.00125	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.04e-05	0.00124	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP2S1—psoriasis	4.97e-05	0.00123	CbGpPWpGaD
Probenecid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.97e-05	0.00123	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	4.87e-05	0.0012	CbGpPWpGaD
Probenecid—PANX1—Immune System—IFNG—psoriasis	4.82e-05	0.00119	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.75e-05	0.00117	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	4.73e-05	0.00117	CbGpPWpGaD
Probenecid—PANX1—Immune System—CD4—psoriasis	4.66e-05	0.00115	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.64e-05	0.00114	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.61e-05	0.00114	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.61e-05	0.00114	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NDUFA5—psoriasis	4.58e-05	0.00113	CbGpPWpGaD
Probenecid—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.55e-05	0.00112	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.54e-05	0.00112	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.51e-05	0.00111	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	4.45e-05	0.0011	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IFNG—psoriasis	4.44e-05	0.0011	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP2S1—psoriasis	4.33e-05	0.00107	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—IL6—psoriasis	4.32e-05	0.00107	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.31e-05	0.00106	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CARM1—psoriasis	4.3e-05	0.00106	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.27e-05	0.00105	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	4.26e-05	0.00105	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	4.24e-05	0.00105	CbGpPWpGaD
Probenecid—PANX1—Immune System—JUN—psoriasis	4.17e-05	0.00103	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.11e-05	0.00101	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	4.06e-05	0.001	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.02e-05	0.000991	CbGpPWpGaD
Probenecid—PANX1—Immune System—NFKB1—psoriasis	4.01e-05	0.00099	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NDUFA5—psoriasis	3.99e-05	0.000985	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP2S1—psoriasis	3.9e-05	0.000961	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NDUFA5—psoriasis	3.72e-05	0.000918	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	3.71e-05	0.000915	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—NFKB1—psoriasis	3.69e-05	0.000912	CbGpPWpGaD
Probenecid—PANX1—Immune System—STAT3—psoriasis	3.61e-05	0.00089	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.54e-05	0.000873	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.53e-05	0.000871	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.53e-05	0.00087	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	3.46e-05	0.000853	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP2S1—psoriasis	3.39e-05	0.000837	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IFNG—psoriasis	3.37e-05	0.000831	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—NOS2—psoriasis	3.36e-05	0.00083	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.36e-05	0.00083	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	3.3e-05	0.000814	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CARM1—psoriasis	3.29e-05	0.000813	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP2S1—psoriasis	3.16e-05	0.00078	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.13e-05	0.000773	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CARM1—psoriasis	3.06e-05	0.000756	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.94e-05	0.000725	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.94e-05	0.000724	CbGpPWpGaD
Probenecid—ALB—Platelet degranulation—VEGFA—psoriasis	2.87e-05	0.000709	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TNF—psoriasis	2.87e-05	0.000709	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.85e-05	0.000703	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.82e-05	0.000695	CbGpPWpGaD
Probenecid—ALB—Hemostasis—ITGAL—psoriasis	2.77e-05	0.000682	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.74e-05	0.000676	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CAT—psoriasis	2.64e-05	0.000652	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.61e-05	0.000643	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.58e-05	0.000637	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.54e-05	0.000628	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TP53—psoriasis	2.53e-05	0.000625	CbGpPWpGaD
Probenecid—PANX1—Immune System—IL6—psoriasis	2.52e-05	0.000622	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NOS2—psoriasis	2.51e-05	0.000619	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NDUFA5—psoriasis	2.5e-05	0.000617	CbGpPWpGaD
Probenecid—ALB—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000614	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CARM1—psoriasis	2.43e-05	0.000599	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.33e-05	0.000576	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.32e-05	0.000572	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IL6—psoriasis	2.32e-05	0.000572	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.31e-05	0.000571	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.28e-05	0.000563	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.27e-05	0.00056	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.27e-05	0.00056	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NDUFA5—psoriasis	2.23e-05	0.000551	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.21e-05	0.000544	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TNF—psoriasis	2.18e-05	0.000538	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NDUFA5—psoriasis	2.18e-05	0.000538	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.17e-05	0.000535	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP2S1—psoriasis	2.13e-05	0.000525	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000522	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CARM1—psoriasis	2.11e-05	0.000522	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.08e-05	0.000514	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—APOE—psoriasis	2.05e-05	0.000507	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.04e-05	0.000504	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NDUFA5—psoriasis	2.04e-05	0.000502	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CAT—psoriasis	2.03e-05	0.0005	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.03e-05	0.0005	CbGpPWpGaD
Probenecid—ABCC5—Disease—HLA-A—psoriasis	2.01e-05	0.000497	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.98e-05	0.000488	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—VEGFA—psoriasis	1.95e-05	0.000481	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.93e-05	0.000477	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CARM1—psoriasis	1.9e-05	0.000469	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000469	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.9e-05	0.000469	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CAT—psoriasis	1.88e-05	0.000465	CbGpPWpGaD
Probenecid—ABCC5—Disease—APOE—psoriasis	1.88e-05	0.000464	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2S1—psoriasis	1.85e-05	0.000457	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.84e-05	0.000455	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PPARG—psoriasis	1.79e-05	0.000441	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-05	0.000439	CbGpPWpGaD
Probenecid—ABCC5—Disease—NOS2—psoriasis	1.75e-05	0.000432	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2S1—psoriasis	1.73e-05	0.000427	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CARM1—psoriasis	1.66e-05	0.000409	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—APOE—psoriasis	1.57e-05	0.000388	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CARM1—psoriasis	1.54e-05	0.000381	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CAT—psoriasis	1.49e-05	0.000369	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—psoriasis	1.47e-05	0.000363	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—APOE—psoriasis	1.46e-05	0.000361	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VEGFA—psoriasis	1.45e-05	0.000358	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.44e-05	0.000355	CbGpPWpGaD
Probenecid—ABCC5—Disease—TYK2—psoriasis	1.43e-05	0.000354	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.38e-05	0.000341	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PPARG—psoriasis	1.37e-05	0.000338	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NDUFA5—psoriasis	1.34e-05	0.000331	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CAT—psoriasis	1.3e-05	0.000321	CbGpPWpGaD
Probenecid—ABCC5—Disease—CD4—psoriasis	1.3e-05	0.00032	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.28e-05	0.000315	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PPARG—psoriasis	1.27e-05	0.000315	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.26e-05	0.00031	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CAT—psoriasis	1.17e-05	0.000289	CbGpPWpGaD
Probenecid—ABCC1—Disease—HLA-A—psoriasis	1.16e-05	0.000287	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—APOE—psoriasis	1.16e-05	0.000286	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000282	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NOS2—psoriasis	1.13e-05	0.00028	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000275	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000274	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—psoriasis	1.1e-05	0.000271	CbGpPWpGaD
Probenecid—ABCC1—Disease—APOE—psoriasis	1.09e-05	0.000268	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.08e-05	0.000266	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CARM1—psoriasis	1.04e-05	0.000256	CbGpPWpGaD
Probenecid—ALB—Metabolism—CARM1—psoriasis	1.03e-05	0.000255	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CAT—psoriasis	1.02e-05	0.000251	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOS2—psoriasis	1.01e-05	0.00025	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PPARG—psoriasis	1.01e-05	0.000249	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—APOE—psoriasis	1.01e-05	0.000249	CbGpPWpGaD
Probenecid—ABCC5—Disease—STAT3—psoriasis	1e-05	0.000248	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.95e-06	0.000246	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.71e-06	0.00024	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.66e-06	0.000238	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CAT—psoriasis	9.5e-06	0.000234	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.49e-06	0.000234	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CARM1—psoriasis	9.27e-06	0.000229	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—APOE—psoriasis	9.09e-06	0.000224	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.08e-06	0.000224	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CARM1—psoriasis	9.05e-06	0.000223	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PPARG—psoriasis	8.8e-06	0.000217	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.67e-06	0.000214	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CARM1—psoriasis	8.46e-06	0.000209	CbGpPWpGaD
Probenecid—ABCC1—Disease—TYK2—psoriasis	8.29e-06	0.000204	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PPARG—psoriasis	7.92e-06	0.000195	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—APOE—psoriasis	7.92e-06	0.000195	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.9e-06	0.000195	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—psoriasis	7.5e-06	0.000185	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—psoriasis	7.38e-06	0.000182	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—psoriasis	7.02e-06	0.000173	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—psoriasis	6.9e-06	0.00017	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—psoriasis	6.57e-06	0.000162	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—psoriasis	6.43e-06	0.000159	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAT—psoriasis	6.39e-06	0.000158	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAT—psoriasis	6.35e-06	0.000157	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—psoriasis	5.8e-06	0.000143	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAT—psoriasis	5.7e-06	0.000141	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CARM1—psoriasis	5.58e-06	0.000138	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAT—psoriasis	5.57e-06	0.000137	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAT—psoriasis	5.2e-06	0.000128	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—psoriasis	4.97e-06	0.000123	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—psoriasis	4.97e-06	0.000123	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—psoriasis	4.94e-06	0.000122	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—psoriasis	4.43e-06	0.000109	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—psoriasis	4.33e-06	0.000107	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—psoriasis	4.33e-06	0.000107	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—psoriasis	4.3e-06	0.000106	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—psoriasis	4.05e-06	0.0001	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—psoriasis	4.04e-06	9.97e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—psoriasis	3.86e-06	9.53e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—psoriasis	3.77e-06	9.3e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—psoriasis	3.52e-06	8.69e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAT—psoriasis	3.43e-06	8.46e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—psoriasis	2.67e-06	6.58e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—psoriasis	2.32e-06	5.73e-05	CbGpPWpGaD
